Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Shareholders' Equity - Schedule of Weighted Average Exercise Prices and Modification in Option Plans of Employees, Directors and Consultants (Details)

v3.25.1
Shareholders' Equity - Schedule of Weighted Average Exercise Prices and Modification in Option Plans of Employees, Directors and Consultants (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Schedule of Weighted Average Exercise Prices Share Options [Abstract]    
Number of options, Granted   50,000,000
Weighted average exercise price, Granted   $ 0
Weighted average remaining contractual terms, Granted   9 years 10 months 6 days
Aggregate intrinsic value , Granted  
Number of options, Forfeited/expired   (7,648,000)
Weighted average exercise price, Forfeited/expired  
Forfeited/expired  
Aggregate intrinsic value, Forfeited/expired  
Number of options, Outstanding Ending 82,477,000 124,829,000
Weighted average exercise price, Outstanding Ending $ 0.04 $ 0.03
Weighted average remaining contractual terms, Outstanding Ending 8 years 4 months 24 days 7 years 1 month 6 days
Aggregate intrinsic value, Outstanding Ending
Number of options, Vested and expected to vest   124,829,000
Weighted average exercise price, Vested and expected to vest   $ 0.03
Weighted average remaining contractual terms, Vested and expected to vest   7 years 1 month 6 days
Aggregate intrinsic value, Vested and expected to vest  
Number of options, Exercisable   46,019,625
Weighted average exercise price, Exercisable   $ 0.07
Weighted average remaining contractual terms, Exercisable   5 years 10 months 24 days
Aggregate intrinsic value, Exercisable